Article

Methicillin-resistant Staphylococcus aureus in orthopaedic trauma: identification of risk factors as a strategy for control of infection.

The Edinburgh Orthopaedic Trauma Unit, The Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA, UK.
Journal of Bone and Joint Surgery - British Volume (Impact Factor: 2.69). 03/2009; 91(2):249-52. DOI: 10.1302/0301-620X.91B2.21339
Source: PubMed

ABSTRACT We have conducted a case-control study over a period of ten years comparing both deep infection with methicillin-resistant staphylococcus aureus (MRSA) and colonised cases with a control group. Risk factors associated with deep infection were vascular diseases, chronic obstructive pulmonary disease, admission to a high-dependency or an intensive-care unit and open wounds. Those for colonisation were institutional care, vascular diseases and dementia. Older age was a risk factor for any MRSA infection. The length of hospital stay was dramatically increased by deep infection. These risk factors are useful in identifying higher-risk patients who may be more susceptible to MRSA infection. A strategy of early identification and isolation may help to control its spread in trauma units.

0 Bookmarks
 · 
51 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of serious bacterial infection in the horse, with an increasing number of cases reported over the last decade. MRSA, along with other commensal staphylococcal species, can reside on the mucosa of several sites in the horse, particularly the nose. Nasal carriage of MRSA appears rare amongst horses in the community, although a higher prevalence has been found in hospitalised horses. MRSA infections can involve a variety of body sites, but most commonly encountered are soft tissue infections of either traumatic or surgical wounds. MRSA strain types isolated from horses are typically multidrug-resistant and usually differ from those recovered from humans and other small animal species. Treatment of infection can be prolonged and is dependent on timely, accurate diagnosis and on appropriate therapy; often guided by antimicrobial susceptibility testing. The purpose of this review is to provide clinically relevant information for the equine practitioner and, for illustration, the diagnosis, treatment and outcome of 4 clinical cases of MRSA infection in horses is discussed.
    Equine Veterinary Education. 01/2010; 22(2):91 - 102.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Infekcije operativnog mesta predstavljaju jednu od naj~e{}ih lokalizaciju bolni~kih infekcija, a bakterije koje poti~u iz endogene flore paci-jenata su naj~e{}i prouzrokova~i ovih infekcija. Cilj ovog rada je bio da se odredi incidencija in-fekcija operativnog mesta (IOM), kao i da se utvrde naj~e{}i prouzrokova~i IOM i njihova osetljivost na antimikrobne agense na odeljenjima ortopedije i traumatologije. Prospektivnom kohort-nom studijom incidencije tokom {est meseci, bili su obuhva}eni svi pacijenti hospitalizovani na Institutu za ortpediju i traumatologiju Klini~kog centra Srbije. Dijagnoza infekcija operativnog mesta postavljana je na osnovu definicija ovih infekcija, a identifi-kacija mikoroorganizama je izvr{ena standardnim mikrobiolo{kim metodama. Od ukupno 277 operi-sanih pacijenata, 63 je razvilo po jednu infekciju op-erativnog mesta, tako da je stopa incidencije iznosila 22,7% (95% IP=17,8-27,6). Infekcije su zna~ajno ~e{}e nastajale kod prljavih i inficiranih rana (?2=67,6; DF=3 p,001). Laboratori-jsku potvrdu je imalo 84,1% infekcija, a ukupni broj izolata iznosio je 82. Najvi{e je je bio zastupljen Staphyloccocus aureus (29,3%) od kojih je 79,2% bilo rezistentno na meticilin, a zatim Acinetobacter sp, Klebsiella sp, Pseudomonas sp i Enterococcus sp. Ovim radom je pokazano da je na odeljenjima or-topedije i hirurgije potrebno vr{iti kontinuirani nadzor nad infekcijama operativnog mesta kao i sprovoditi mere prevencije i spre~avanja {irenja bakterija rezistntnih na antibiotike. Klju~ne re~i: infekcije operativnog mesta ortopedija, etiologija UVOD I nfekcije operativnog mesta (IOM) su, prema definici-jama Centra za prevenciju i kontrolu zaraznih bolesti (CDC) iz Atlante 1 , a koje su prihva}ene i u na{oj 2 kao i u svim zemljama sveta, one infekcije koje su nas-tale u okviru 30 dana od operacije, odnosno u toku godine dana od ugradivanja proteze ili implantata. Uprkos sve ve}im saznanjima, IOM i dalje imaju vi-soku incidenciju i mortalitet i optere}uju zdravstvene sisteme zemalja ogromnim tro{kovima. IOM pred-stavljaju jednu od naj~e{}ih lokalizaciju bolni~kih in-fekcija (BI) 3,4 . Stope incidencije IOM u razvijenim zemljama su, po pravilu, ni'e 5,6 , a stope incidencije u nerazvijenim zemljama, odnosno zemljama koje tek uspostavljaju nadzor nad BI, ~esto su vi{e od 25% 7 . Podaci iz evropskih zemalja govore da stope inciden-cije IOM mogu biti 15-20% u zavisnoti od vrste hirur{ke intervencije 8 . Bakterije su vode}i uzro~nici IOM i vrlo ~esto poti~u u iz endogene flore pacijenata. Prema podacima nacion-alnog sistema nadzora nad BI u SAD, Staphylococcus aureus i koagulaza-negativne stafilokoke su naj~e{}i prouzrokova~i IOM 9 . Ova dva mikroorganizma su bila naj~e{}a i u istra'ivanjima u drugim zemljama 5,10 . Pored njih, registruju se jo{ i Escherichia coli, Klebsiella-enterobacter sp, Pseudomonas sp ili druge bakterije koje poti~u iz egzogenih izvora 11 . U posednjih petnaestak godina, zapa'eno je da su naju~estaliji prouzrokova~i IOM sve ~e{}e otporni na antibiotike. Jedan od najzna~ajnihih problema, kako za le~enje, tako i za ishod operisanog pacijenta, su IOM uzrokovane methicillin-rezistentnim S. aureus-om (MRSA). U nekim istra'ivanjima je zapa'eno da je vi{e od 50% izolata S. aureus bilo methicillin-rezistentno 12 .
    Acta chirurgica iugoslavica 02/2009; 56(2):81-86.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Complicated skin and soft tissue infections (cSSTIs) are a diverse group of infections, with a range of presentations and microbiological causes. Hospitalization is common for patients with a cSSTI, which is treated by drainage of the affected area and with antibiotics. Host factors such as co-morbidities, and microbial factors, in particular drug resistance, complicate the management of these infections. Methicillin-resistant Staphylococcus aureus (MRSA) is an important cSSTI pathogen in Europe, and its involvement can be associated with poor patient outcomes. European guidelines recommend vancomycin, teicoplanin, linezolid, daptomycin, tigecycline or ceftaroline for treatment of MRSA cSSTIs. Of primary importance when treating cSSTIs is the agent's clinical efficacy against the causative pathogens, as well as its bioavailability in the skin and associated structures. Linezolid is well-suited for the treatment of MRSA cSSTIs; it achieves high penetration into skin and soft tissues with 100% oral bioavailability, and therefore enables an intravenous to oral switch and outpatient treatment. When eligible patients are offered oral therapy the associated length of hospital stay and overall costs can be reduced. Linezolid has demonstrated clinical efficacy and favourable outcomes in patients for the treatment of MRSA cSSTIs including the treatment of lower extremity infections. Furthermore, efficacy has been documented in key defined populations, such as individuals with renal impairment and the obese. The safety profile of linezolid is well-documented, making this antibacterial a viable choice for the treatment of MRSA cSSTIs.
    Clinical Microbiology and Infection 04/2014; 20 Suppl 4:3-18. · 4.58 Impact Factor